M.I. Bruce et al. / Journal of Organometallic Chemistry 756 (2014) 68e78
77
Table 1
Crystal data and refinement details for 2, 4, 6, 7, 9.
Complex
2
4
6
7
9
CCDC #
Formula
MW
887533
705436
C44H42N2OP2Ru
777.81
887534
C46H40N4OP2Ru$0.386CH2Cl2
860.61
887535
C46H44N4P2Ru$0.30CH2Cl2
841.09
887536
C47H41N5P2Ru
838.86
C96H98N6P4Ru2Si2$2H2O
1754.04
Crystal system
Space group
Monoclinic
P21/n
9.1099(1)
19.9990(5)
24.6501(5)
Monoclinic
P21
12.4183(2)
10.4022(2)
14.2891(2)
Tetragonal
P4/n
27.107(2)
27.107(2)
11.727(5)
Monoclinic
P21/n
12.0547(10)
20.0027(4)
16.9280(10)
Triclinic
P1
ꢀ
a/A
11.7031(11)
11.9711(10)
16.2496(10)
79.336(6)
87.205(6)
67.758(8)
2070.2(3)
1.346
ꢀ
b/A
ꢀ
c/A
a
/deg.
/deg.
b
96.403(2)
98.860(2)
101.042(8)
g
/deg.
3
ꢀ
V/A
4463.0(2)
1.305
2
1823.81(5)
1.416
2
8617(4)
1.327
8
4006.2(4)
1.394
4
rc (g cmꢁ3
)
Z
2
2
m
qmax/deg.
(Mo-K
)/mmꢁ1
135
4.07 [Cu-K
64
0.56
50
0.53
62
0.55
55
0.50
a
a
]
Tmin/max
0.72
0.94
0.98/1.03
0.26 ꢃ 0.07 ꢃ 0.05
35,352
7576 (0.092)
3152
0.94
0.81
Crystal dimensions/mm3
0.27 ꢃ 0.06 ꢃ 0.05
0.39 ꢃ 0.11 ꢃ 0.05
0.37 ꢃ 0.25 ꢃ 0.15
0.27 ꢃ 0.14 ꢃ 0.12
Reflections collected
55,036
27,774
64,047
17,407
Unique reflections (Rint
Reflections (I > 2 (I))
R1 (I > 2 (I))
wR2 (all data)
)
7959 (0.051)
5535
0.055
11,439 (0.038)
8485
0.033
12,760 (0.035)
9510
0.045
8604 (0.070)
6226
0.061
s
s
0.090
0.239
0.161
0.061
0.123
0.159
was purified by preparative TLC (acetone-hexane, 3/7). Two
major bands were collected: orange (Rf ¼ 0.46) containing Ru
7.62 (m, 20H, Ph). 31P NMR (CDCl3):
d
72.9 (s, dppe). ES-MS
(MeOH þ NaOMe, m/z): 659, [C2Ru(dppe)Cp*]þ; 635, [Ru(dppe)
{C^CCMe]C(CN)2}(dppe)Cp*
3
(R
¼
Me) (8 mg, 24%) [3]
Cp*]þ High resolution MS (m/z): 851.1624, [M þ Na]þ (calcd for
.
and yellow (Rf ¼ 0.38) containing Ru{c-C]CHC[]C(CN)2]CH]C
HO}(dppe)Cp* 4 (6 mg, 17%) as a bright yellow solid. X-ray quality
crystals were grown from CH2Cl2/hexane. IR (CH2Cl2, cmꢁ1):
C46H40N4NaOP2Ru 851.1618).
Band 3 (orange, Rf ¼ 0.23) contained Ru{C^Cec-C]CHC[]C(
CN)2]NHCMe]N}(dppe)Cp* 7 (8 mg,16%). Single crystals suitable for
n
(C^N) 2194m, 2170w,
NMR (CDCl3):
1.45 (s, 15H, Cp*), 2.48, 2.74 (2ꢃ m, 2ꢃ CH2, dppe),
5.85 [dd, J(HH) ¼ 5.6, 2.3 Hz, 1H, H], 6.33 [d, J(HH) ¼ 5.6 Hz, 1H, H],
6.54 (s, 1H, H), 7.13e7.38 (m, 20H, Ph). 13C NMR (CDCl3):
10.16 (s,
n
(C]C) 1620s, 1476m, 1453s, 1436w. 1H
X-ray studies were grown from CH2Cl2/hexane. IR (CH2Cl2, cmꢁ1):
d
n
(CH) 2926m,
1529 (w). 1H NMR (CDCl3):
3H, CH), 2.13e2.18, 2.27e2.31 (2ꢃ m, 2ꢃ 2H, CH2CH2), 4.19 (s, H, NH),
n
(CN) 2204m,
n
(C^C) 2024m;
n(C]C) 1644 (w); n(NH)
d
1.26 (s, H, Me), 1.54 (s, 15H, Cp*), 2.17 (s,
d
C5Me5), 28.66e31.16 (m, dppe), 95.61 (s, C5Me5), 107.94, 124.19,
148.70, 153.53 (4ꢃ s, C), 119.17, 119.63 (2ꢃ s, CN), 127.94e137.92 (m,
7.07e7.63 (m, 20H, Ph). 31P NMR (CDCl3):
d 79.7 (s, dppe). ES-MS
(MeOH, m/z): 816, [M]þ; 635, [Ru(dppe)Cp*]þ High resolution MS
.
Ph), 217.04 (m, RueC). 31P NMR (CDCl3):
d
93.6 [s, 2P, Ru(dppe)]. ES-
(m/z): 817.211, [M ꢁ Me]þ (calcd for C45H41N4OP2Ru, 817.180).
MS (MeOH, m/z): 778, Mþ (calcd C44H42N2OP2Ru, 778); 635,
[Ru(dppe)Cp*]þ; HR-MS: [M þ H]þ 779.201 (calcd 779.189);
[M þ Na]þ 801.184 (801.171).
4.5.2. With Ru(C^CC^CI)(dppe)Cp* 8
To a solution of Ru(C^CC^CH)(dppe)Cp* (156 mg, 0.23 mmol)
in THF (10 ml) at ꢁ78 ꢂC was added LiBu (0.10 ml, 2.5 M in hexanes,
0.25 mmol) and stirred for 5 min. [I(py)2]BF4 (88 mg, 0.24 mmol)
was then added and the mixture was stirred 20 min to give a so-
lution containing Ru(C^CC^CI)(dppe)Cp* 8. TCNE (33 mg,
0.26 mmol) was added at ꢁ78 ꢂC and the vessel allowed to warm to
r.t. Solvent was removed and the residue purified by preparative
TLC (1% acetone/dichloromethane) to afford dark purple Ru
{C^CC]C(CN)2CI]C(CN)2}(dppe)Cp* (99 mg, 46%) [20] and pink
Ru{C^Cec-C]C(CN)C(NH2)]C(CN)C(CN)2}(dppe)Cp* 9 (20 mg,
10%). X-ray quality crystals were grown from CH2Cl2/hexane. Anal.
Calcd (C47H41N5P2Ru): C, 67.29; H, 4.93; N, 8.35; M, 839. Found: C,
4.5. Reactions of TCNE
4.5.1. With Ru(C^CC^CLi)(dppe)Cp*
A solution of Ru(C^CC^CH)(dppe)Cp* (50 mg, 0.07 mmol) in
THF (5 ml) was treated with LiBu (70 mL, 1.5 M solution in hexanes)
and stirred for 30 min at ꢁ78 ꢂC. TCNE (9 mg, 0.07 mmol) was
added and the mixture was stirred at ꢁ78 ꢂC for 30 min and then at
r.t. for 4 h. Solvent was removed and the residue was dissolved in
minimum amount of CH2Cl2 and purified by preparative TLC. Three
bands separated with CH2Cl2 as eluant. Band 1 (red, Rf ¼ 0.33)
66.67; H, 4.88; N, 8.16. IR (Nujol, cmꢁ1):
2200w (sh), 2185m, (C^C) 1984s, (C]C) 1654w, 1575w, 1507m.
1H NMR (CDCl3):
1.61 (s, 15H, Cp*), 2.36, 2.95 (2ꢃ m, 2ꢃ CH2,
dppe), 5.10 (s, 2H, NH2), 7.15e7.58 (m, 20H, Ph). 13C NMR (CDCl3):
n(NH) 3453 (br), n(CN)
contained {Ru(dppe)Cp*}2{m-C^CC[]C(CN)2]C[]C(CN)2]C^C} 5
n
n
(35 mg, 32%). Anal. Calcd. (C82H80N4P4Ru2): C, 68.65; H, 5.35; N,
3.81. Found: C, 68.71; H, 5.79; N, 3.72. IR (CH2Cl2, cmꢁ1):
(CN)
1.51 [t,
d
n
2208w, 2075w; n d
(C^C) 1967 (sh), 1866m. 1H NMR (CDCl3):
4J(HP) ¼ 2 Hz, 30H, Cp*], 1.98, 2.44 (2ꢃ m, 2ꢃ 4H, CH2P), 6.77e7.71
d
10.01 (C5Me5), 29.69 (m, PCH2), 96.90 (s, C5Me5), 110.53, 114.46,
114.70 (3ꢃ s, CN),123.87,162.59 (2ꢃ s, C) 127.91e134.90 (m, Ph). 31
P
(m, 40H, Ph). 31P NMR (CDCl3):
d
79.9, 81.3 [AB q, 3J(PP) ¼ 13 Hz,
dppe]. ES-MS (m/z): 1493, [M þ Na]þ; 635, [Ru(dppe)Cp*]þ
NMR (CDCl3):
d
81.2 (s, dppe). ES-MS (MeOH þ NaOMe, m/z): 1496,
.
[M þ Na þ Ru(dppe)Cp*]þ; 862, [M þ Na]þ; 635, [Ru(dppe)Cp*]þ.
HR-MS: [M þ Na]þ, 862.183 (calcd 862.177).
Band 2 (blue, Rf ¼ 0.27) afforded Ru{C^Cec-C]C(CN)C(O)NHC
[]C(CN)2]}-(dppe)Cp* 6 (10 mg, 20%). Single crystals suitable for X-
ray studies were grown from CH2Cl2/hexane. Anal. Calcd.
(C46H40N4OP2Ru): C, 66.65; H, 4.87; N, 6.76. Found: C, 66.54; H,
4.6. Structure determinations
5.44; N, 6.44. IR (CH2Cl2, cmꢁ1):
(C^C) 1954m, (CO) 1716m,
1.68 (s, 15H, Cp*), 1.76e1.83, 2.68e2.74 (2ꢃ m, 4H, CH2CH2), 7.23e
n
(NH) 3058w;
n(CN) 2212w,
n
n
n
(C]C) 1603w. 1H NMR (CDCl3):
Crystallographic data for the structures were collected at
100(2) K on CCD diffractometers fitted with Mo-Ka radiation,
d